Alternatives to statins in intolerant patients do lower cholesterol, study findsBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i1926 (Published 05 April 2016) Cite this as: BMJ 2016;353:i1926
- Ingrid Torjesen
Statins do cause painful muscle cramps in some patients, and alternative drugs can reduce low density lipoprotein cholesterol (LDL-C) levels, a two stage randomised clinical trial published online in JAMA has shown.1
Some patients taking statins report muscle pain or weakness when treatment is initiated or dosage increases, as well as relief when the drug is discontinued or dosage reduced. As a result, some at high risk of major cardiovascular events due to high cholesterol levels may be treated with low dose or intermittent statins or, alternatively, the cholesterol absorption inhibitor ezetimibe—but these strategies seldom achieve the cholesterol reductions recommended by current guidelines.
However, the results of a trial funded by Amgen, which markets proprotein convertase subtilisin/kexin type 9 (PCSK9), showed that evolocumab was more effective than ezetimibe at lowering LDL-C in statin intolerant patients.
The study involved 511 adult …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial